Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Osiris Therapeutics (OSIR)

Osiris Therapeutics (OSIR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 655,687
  • Shares Outstanding, K 34,528
  • Annual Sales, $ 142,820 K
  • Annual Income, $ 36,900 K
  • 60-Month Beta 0.88
  • Price/Sales 4.59
  • Price/Cash Flow 17.53
  • Price/Book 8.35
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.18
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 04/03/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.90 +0.48%
on 04/09/19
19.27 -1.45%
on 03/20/19
-0.07 (-0.37%)
since 03/15/19
3-Month
13.56 +40.04%
on 02/06/19
19.30 -1.61%
on 03/11/19
+4.40 (+30.16%)
since 01/16/19
52-Week
7.01 +170.90%
on 04/23/18
19.30 -1.61%
on 03/11/19
+10.99 (+137.38%)
since 04/16/18

Most Recent Stories

More News
Active Wound Care Market to Value at US$ 2039.9 Mn at 5.3% CAGR by 2025 | Exclusive Report by Fortune Business Insights

Fortune Business Insights published a report, titled "Active Wound Care Market Size, Share and Global Trend by Product Type (Biological Skin Equivalents, Growth Factors, Biological Dressings), Indication...

OSIR : 18.99 (unch)
SNN : 46.97 (+0.45%)
Osiris Therapeutics, Inc. Announces Closing of Acquisition by Smith & Nephew plc

Osiris Therapeutics, Inc. (NASDAQ: OSIR), a regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, announced today that it has completed...

SNN : 46.97 (+0.45%)
OSIR : 18.99 (unch)
Gainey McKenna & Egleston Announces that It Filed a Class Action Lawsuit Against Osiris Therapeutics, Inc. (OSIR) And Its Directors

Gainey McKenna & Egleston announces that it filed a class action lawsuit against Osiris Therapeutics, Inc. ("OSIR" or the "Company") (Nasdaq: OSIR) and its board of directors (the "Board"), on behalf of...

SNN : 46.97 (+0.45%)
OSIR : 18.99 (unch)
OSIRIS SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces an Investigation of Osiris Therapeutics, Inc. (OSIR) Over the Proposed Merger of the Company with Smith & Nephew plc

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating the proposed merger of Osiris Therapeutics, Inc. ("OSIRIS" or the "Company") (NASDAQ:OSIR) with Smith & Nephew plc.

OSIR : 18.99 (unch)
Lifshitz & Miller LLP Announces Investigation of Amarin Corporation plc, Clementia Pharmaceuticals Inc., CVS Health Corporation, Diplomat Pharmacy, Inc., GTx, Inc., Multi-Color Corporation, Osiris Therapeutics, Inc., and The Kraft Heinz Company

Amarin Corporation plc (AMRN)

AMRN : 15.21 (-0.07%)
CMTA : 26.35 (-0.11%)
CVS : 62.80 (-0.22%)
DPLO : 4.66 (+0.43%)
GTXI : 1.20 (unch)
KHC : 27.06 (-0.07%)
LABL : 50.01 (+0.08%)
OSIR : 18.99 (unch)
SHAREHOLDER ALERT: WeissLaw LLP Investigates Osiris Therapeutics, Inc.

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Osiris Therapeutics, Inc. ("OSIR" or the "Company") (NASDAQ: OSIR) in connection...

OSIR : 18.99 (unch)
OSIRIS THERAPEUTICS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout

Rigrodsky & Long, P.A.:

OSIR : 18.99 (unch)
SNN : 46.97 (+0.45%)
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Osiris Therapeutics, Inc. - OSIR

Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating Osiris Therapeutics,...

SNN : 46.97 (+0.45%)
OSIR : 18.99 (unch)
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Osiris Therapeutics, Inc.

Rowley Law PLLC is investigating potential claims against Osiris Therapeutics, Inc. (NASDAQ: OSIR) and its board of directors for breach of fiduciary duty concerning the proposed acquisition of the company...

OSIR : 18.99 (unch)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Osiris Therapeutics, Inc. to Smith & Nephew plc is Fair to Shareholders

The following statement is being issued by Levi & Korsinsky, LLP:

SNN : 46.97 (+0.45%)
OSIR : 18.99 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

See More Share

Trade OSIR with:

Business Summary

OSIRIS THERAPEUTICS, INC. is a leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas. Osiris currently markets and sells Osteocel for regenerating bone in orthopedic indications. Prochymal...

See More

Key Turning Points

2nd Resistance Point 19.03
1st Resistance Point 19.01
Last Price 18.99
1st Support Level 18.97
2nd Support Level 18.95

See More

52-Week High 19.30
Last Price 18.99
Fibonacci 61.8% 14.61
Fibonacci 50% 13.15
Fibonacci 38.2% 11.70
52-Week Low 7.01

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar